Pfizer Inc. Shuffles U.S. Executives Amid Reorganization

NEW YORK, Feb 27 (Reuters) - Pfizer Inc. (PFE.N: Quote, Profile, Research), the world's largest drug maker, on Monday confirmed it has shuffled leadership responsibilities atop its U.S. division amid a broader redeployment of senior executives.
MORE ON THIS TOPIC